Clinical Performance of Injectable Universal Flowable Composite in Proximal Cavities of Posterior… (NCT05263089) | Clinical Trial Compass
CompletedNot Applicable
Clinical Performance of Injectable Universal Flowable Composite in Proximal Cavities of Posterior Teeth.
Egypt30 participantsStarted 2022-04-01
Plain-language summary
The aim of the study is to evaluate the clinical performance of injectable universal flowable composite vs conventional resin composite restorations in proximal cavities of posterior teeth. The null hypothesis is proposed that there will be no difference in the clinical performance of injectable universal flowable composite versus conventional resin composite restorations in proximal cavities of posterior teeth. The design for this randomized controlled clinical trial is a superiority framework with parallel groups with equal allocation ratios. The patients are randomly divided into two groups where one group will receive conventional resin composite and the other group will receive injectable universal flowable resin composite. The restorations will be evaluated for any fracture or loss of retention by using prob following Modified USPHS criteria at baseline, 3, 6, 12 month.
Who can participate
Age range
18 Years – 55 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Participant Inclusion Criteria
* Adult patients aged 18-55 years.
* Patients with good oral hygiene (mild to moderate plaque accumulation).
* patients with asymptomatic compound proximal cavities in permanent posterior teeth.
* ICDAS (3 \&4)
Teeth inclusion criteria
* Vital posterior teeth with compound proximal cavities.
* Teeth with no or minimum mobility
* No history of hypersensitivity in the teeth to be restored
* Free from signs and symptoms of pulpitis and pulpal necrosis.
Participant Exclusion criteria
* Patients who are unable to return for recall appointments.
* Patients with poor oral hygiene.
* Presence of abnormal oral, medical, or mental condition
* Patients with untreated extra occlusal stresses
* Patients with TMJ problems.
Teeth Exclusion criteria
* Root involvement.
* Periodontal disease that may affect the prognosis of the restoration or the tooth itself.
* Fractured or visibly cracked teeth.
* Presence of any developmental or formative defects.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Criteria of restoration evaluation indicating clinical performance.